Lucio Crinò

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer”.

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

New England Journal of Medicine(2015)10.1056/nejmoa1507643

N/A

1.4DataRank · unranked

9414 citations

Luis Paz-Ares, Diane P Holder, David R. Spigel, Martin Steins, Neal E. Ready +38 more

Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies

British Journal of Cancer(2025)10.1038/s41416-025-03139-6

N/A

0.104DataRank · unranked

1 citations

Lucio Crinò, Luca Braga, Francesco Salton, Barbara Ruaro, Marco Confalonieri +3 more